Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Sci Adv ; 6(14): eaay4472, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-32270035

RESUMEN

The potassium channel Kv7.1 associates with the KCNE1 regulatory subunit to trigger cardiac I Ks currents. Although the Kv7.1/KCNE1 complex has received much attention, the subcellular compartment hosting the assembly is the subject of ongoing debate. Evidence suggests that the complex forms either earlier in the endoplasmic reticulum or directly at the plasma membrane. Kv7.1 and KCNE1 mutations, responsible for long QT syndromes, impair association and traffic, thereby altering I Ks currents. We found that Kv7.1 and KCNE1 do not assemble in the first stages of their biogenesis. Data support an unconventional secretory pathway for Kv7.1-KCNE1 that bypasses Golgi. This route targets channels to endoplasmic reticulum-plasma membrane junctions, where Kv7.1-KCNE1 assemble. This mechanism helps to resolve the ongoing controversy about the subcellular compartment hosting the association. Our results also provide new insights into I Ks channel localization at endoplasmic reticulum-plasma membrane junctions, highlighting an alternative anterograde trafficking mechanism for oligomeric ion channels.


Asunto(s)
Canal de Potasio KCNQ1/metabolismo , Complejos Multiproteicos/metabolismo , Canales de Potasio con Entrada de Voltaje/metabolismo , Transporte Biológico , Biomarcadores , Técnica del Anticuerpo Fluorescente , Genes Reporteros , Humanos , Activación del Canal Iónico , Miocitos Cardíacos/metabolismo , Unión Proteica
2.
Cell Mol Life Sci ; 73(7): 1515-28, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26542799

RESUMEN

The potassium channel Kv1.3 plays roles in immunity, neuronal development and sensory discrimination. Regulation of Kv1.3 by kinase signaling has been studied. In this context, EGF binds to specific receptors (EGFR) and triggers tyrosine kinase-dependent signaling, which down-regulates Kv1.3 currents. We show that Kv1.3 undergoes EGF-dependent endocytosis. This EGF-mediated mechanism is relevant because is involved in adult neural stem cell fate determination. We demonstrated that changes in Kv1.3 subcellular distribution upon EGFR activation were due to Kv1.3 clathrin-dependent endocytosis, which targets the Kv1.3 channels to the lysosomal degradative pathway. Interestingly, our results further revealed that relevant tyrosines and other interacting motifs, such as PDZ and SH3 domains, were not involved in the EGF-dependent Kv1.3 internalization. However, a new, and yet undescribed mechanism, of ERK1/2-mediated threonine phosphorylation is crucial for the EGF-mediated Kv1.3 endocytosis. Our results demonstrate that EGF triggers the down-regulation of Kv1.3 activity and its expression at the cell surface, which is important for the development and migration of adult neural progenitors.


Asunto(s)
Endocitosis/efectos de los fármacos , Factor de Crecimiento Epidérmico/farmacología , Canal de Potasio Kv1.3/metabolismo , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Animales , Butadienos/farmacología , Células Cultivadas , Clatrina/antagonistas & inhibidores , Clatrina/genética , Clatrina/metabolismo , Regulación hacia Abajo/efectos de los fármacos , Dinamina II/antagonistas & inhibidores , Dinamina II/genética , Dinamina II/metabolismo , Receptores ErbB/genética , Receptores ErbB/metabolismo , Células HEK293 , Células HeLa , Humanos , Canal de Potasio Kv1.3/genética , Ventrículos Laterales/citología , Ventrículos Laterales/metabolismo , Ratones , Proteína Quinasa 1 Activada por Mitógenos/antagonistas & inhibidores , Proteína Quinasa 3 Activada por Mitógenos/antagonistas & inhibidores , Células-Madre Neurales/citología , Células-Madre Neurales/metabolismo , Nitrilos/farmacología , Fosforilación/efectos de los fármacos , Interferencia de ARN , Transducción de Señal/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA